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Abstract
Sepsis is a consequence of systemic bacterial infections leading to hyper activation of immune cells by bacterial products
resulting in enhanced release of mediators of inflammation. Endotoxin (LPS) is a major component of the outer membrane
of Gram negative bacteria and a critical factor in pathogenesis of sepsis. Development of antagonists that inhibit the storm
of inflammatory molecules by blocking Toll like receptors (TLR) has been the main stay of research efforts. We report here
that a filarial glycoprotein binds to murine macrophages and human monocytes through TLR4 and activates them through
alternate pathway and in the process inhibits LPS mediated classical activation which leads to inflammation associated with
endotoxemia. The active component of the nematode glycoprotein mediating alternate activation of macrophages was
found to be a carbohydrate residue, Chitohexaose. Murine macrophages and human monocytes up regulated Arginase-1
and released high levels of IL-10 when incubated with chitohexaose. Macrophages of C3H/HeJ mice (non-responsive to LPS)
failed to get activated by chitohexaose suggesting that a functional TLR4 is critical for alternate activation of macrophages
also. Chitohexaose inhibited LPS induced production of inflammatory molecules TNF-a, IL-1b and IL-6 by macropahges in
vitro and in vivo in mice. Intraperitoneal injection of chitohexaose completely protected mice against endotoxemia when
challenged with a lethal dose of LPS. Furthermore, Chitohexaose was found to reverse LPS induced endotoxemia in mice
even 6/24/48 hrs after its onset. Monocytes of subjects with active filarial infection displayed characteristic alternate
activation markers and were refractory to LPS mediated inflammatory activation suggesting an interesting possibility of
subjects with filarial infections being less prone to develop of endotoxemia. These observations that innate activation of
alternate pathway of macrophages by chtx through TLR4 has offered novel opportunities to cell biologists to study two
mutually exclusive activation pathways of macrophages being mediated through a single receptor.
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Introduction
Sepsis and septic shock, one of the most common causes of
admission in intensive care units results in death of nearly 3,
50,000 people every year only in US and Europe [1,2]. The
disease is a consequence of systemic bacterial infections that
stimulates mediators of inflammation due to hyper activation of
phagocytes. Immune cells express pattern recognition receptors
(PRRs) which recognize immunostimulatory microbial products
called PAMPs (pathogen associated molecular pattern) and trigger
production of inflammatory mediators which assist the host in
elimination of infectious agents [3,4]; however hyper induction of
such mediators by dysregulated innate immune cells leads to sepsis
and septic shock [5,6]. In sepsis caused by Gram-negative bacteria,
endotoxin (LPS) activates the immune system through TLR4 and
induces activation of macrophages that produce inflammatory
mediators [7,8]. TLR4 is the signaling receptor for LPS but
doesn’t directly bind to LPS [9–11]. LPS forms a complex with
LPS binding protein and CD14 which in turn delivers LPS to
MD2 and LPS-MD2 complex activates through TLR4 resulting in
dimerization of TLR4 [3] and initiate the signaling process for
production of cytokines and other critical molecules needed for
hyper-inflammation associated with endotoxemia/sepsis [12].
While effective use of antibiotics has resulted in improved
prognosis of sepsis, deterioration of clinical symptoms and mortality
has been attributed to persistent inflammatory cascade. Neutraliza-
tion of inflammation is considered essential for preventing severe
consequences of sepsis [13,14]. Thus developments of antagonists
that block either activation through TLRs or downstream signaling
pathways that inhibit the storm of inflammatory molecules are widely
pursued by several investigators. Antibodies to TLR4 [15,16],
TLR4/MD2 [17] complex or LPS analogs [18,19] have been tested
in animal models for their efficacy to protect against enditoxemia/
Gram-negative sepsis although only LPS analogues have been
undergone clinical trials. Nitrate salts [20], 5c, an inhibitor of
sphingosine kinase [21], oxidized phospholipid [22,23] molecules
have also offered promising results. Despite all these attempts very
few candidate molecules have reached the level of clinical trials. A
very recent report of one of the clinical trial for a promising agent
was found to be ineffective (http://clinicaltrials.pharmaceu-
tical-business-review.com/news/eisai-eritoran-fails-to-meet-primary-
endpoint-in-phase-iii-trial-250111). In this study we report a novel
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different from those documented so far. We demonstrate that a low
molecularweightchito-oligosaccharide,chitohexaose(chtx)delicately
balances the storm of inflammation induced by LPS while
concurrently activating macrophages into a non inflammatory
alternate pathway through TLR4. Administration of chtx protected
mice from endotoxemia prophylactically as well as therapeutically.
The study also offered evidence for induction of two diverse
activation pathways of macrophages through a single receptor,
TLR4. The stimulating ligand appears to determine the activation
phenotype viz; classical pathway by LPS and alternate pathway by
chtx. We stumbled on these findings while searching for the elusive
innate receptors for nematodes.
Results
FAg binds to monocytes/macrophages through TLR4
Our initial studies were designed to identify an innate receptor
on murine or human phagocytes that recognize nematodes.
Biotinylated somatic extracts of adult stage parasites of Setaria
digitata (FAg) and Brugia pahangi bound to surface of human
monocytes as well as to murine bone marrow macrophages
significantly more than the lymphocytes (Figure 1 A–D). Speci-
ficity of biotinylated FAg reacting to monocytes was confirmed by
competitive inhibition with unlabeled FAg (Figure 1 B). C.elegans,a
non-pathogenic nematode also contained a component binding to
human monocytes and murine macrophages (Figure 1C,D). A
glycoprotein (AgW) affinity purified using WGA-Sepharose
column (Figure S1A) was found to be the active component
(Figure 1E,F). Since another filarial glycoprotein ES-62 has been
previously reported to interact with macrophage surface through
TLR4 [24], we tested such a possibility in our system. AgW as well
as FAg competitively inhibited reactivity of antibodies to TLR4 on
surface of murine bone marrow macrophages (Figure 2A, Figure S
1 B,C, Figure S 2 A,B,C) and on human monocytes (Figure 2B,
Figure S 1D,E, Figure S 2 D,E,F). We sought direct proof by
performing a novel solid phase immunoassay developed by us.
Soluble TLR4 present in membrane lysates of human PBMCs
(Figure 2C) and murine bone marrow cells (Figure S 1F) reacted
with FAg/AgW bound to solid phase. Human and murine TLR4
reacted with extracts of other nematodes also viz; Nippostrongylus
brasiliensis, Heligomosomoides polygyrus and Caenorhabditis elegans
(Figure 2C, Figure S 1F) suggesting the presence of conserved
TLR4 binding components in nematodes. Enhanced binding of
labelled FAg to jurkat cells over expressing TLR4 further
confirmed its ability to interact with TLR4 (Figure 2D,E).
Binding of FAg/AgW to TLR4 is mediated by
carbohydrate moieties
Since immunomodulatory properties of helminth products have
been shown to depend on glycan moiety [25] we examined the
possible role of carbohydrates in FAg-TLR4 interaction described
above. Deglycosylated (Figure S 3A) or chitinase treated (Figure S 3B)
FAg failed to competitively inhibit interaction of labeled FAg with
monocyte surface suggesting the involvement of carbohydrate
residues in such interactions. Susceptibility to chitinase also indicated
the role played by chitin or it’s oligomers in FAg interacting with
TLR4. This was tested by competitive inhibition using chitin
oligomers. Binding of AgW to human monocytes was inhibited by
chitosugars of varying size, longer the chain length higher was the
degree of inhibition (Figure 3A). Further, the hexasaccharide,
chitohexaose (chtx) also inhibited reactivity of soluble TLR4 to
AgW on solid phase in a dose dependant manner (Figure 3B). These
results suggested involvement of chitosugar residues present in FAg/
AgWin interaction with TLR4.In silico analysis using crystal structure
of TLR4 and 3D structure of chtx (http://pubchem.ncbi.nlm.nih.
gov/summary/summary.cgi?cid=197182&loc=ec_rcs) also indi-
cated significant affinity between the two molecules (Figure 3C,
Figure S 3C). Based on these observations further biological
characterization were carried out using chtx as described below.
Chtx inhibits LPS induced production of inflammatory
mediators in vitro
The above findings that chtx residues present in FAg or AgW
binds to TLR4 opened up the possibility of using the small
molecular weight chito-oligosaccharide as a potential TLR4
antagonist to block LPS mediated inflammatory responses.
BMDM of normal mice and normal human PBMCs were
stimulated with LPS or chtx for 48 hrs and levels of TNF-a, IL-
1b, IL-6 and nitrites were quantified in culture supernatants. LPS
stimulated significant production of inflammatory mediators while
chtx failed to do so in both murine and human systems (Figure 4
A–E). Induction of genes for production of inflammatory
molecules by LPS and failure to up regulate such genes by chtx
was confirmed by Q-PCR also (Figure 4F). Chtx on the other
hand significantly inhibited LPS mediated inflammatory activation
of mononuclear cells in both the systems (Figure 4 A–E). We then
tested induction of reactive oxygen species (ROS) by LPS and
chtx. Murine BMDMs upon stimulation with LPS significantly up
regulated ROS while chtx failed to do so. Rather chtx significantly
inhibited LPS induced up-regulation of ROS. (Figure 4G) This
observation is significant in the context of a recent report
suggesting that induction of inflammatory cytokines is dependent
on up regulation of ROS [26].
Chtx inhibits production of inflammatory mediators and
protects mice from endotoxemia
For in vivo validation of the above observations, BALB/c mice
were administered a lethal dose of LPS with and without chtx.
Chtx significantly inhibited LPS induced increase in plasma levels
Author Summary
Sepsis is one of the leading causes of death contributing to
mortality as high as 54 percent in intensive care units
across the world. Hyper inflammation induced by bacteria
or bacterial products through Toll like receptors leads to
sepsis and hence current approaches are directed towards
blockade such receptors. While many such candidate
antagonists have shown promise they also result in
induction of inappropriate innate immune responses thus
increasing risk of development of shock leading to death.
In this study we describe a novel approach to treat
endotoxemia associated with sepsis, fundamentally differ-
ent from other reports. Chitohexaose a small molecular
weight polysaccharide by virtue of its ability to bind to
active sites of TLR4 inhibited LPS induced production of
inflammatory mediators by murine macrophages and
human monocytes. Administration of chitohexaose with
LPS blocked endotoxemia leading to mortality of mice.
More significantly, Chitohexaose reversed inflammation
and protected mice even 24/48 hrs after onset of
endotoxemia. Apart from competitively inhibiting LPS
induced inflammation chitohexaose also activated alter-
nate pathway of macrophages. Such macrophages are
known to display increased phagocytic activity, are
resistant to LPS induced activation and associated with
resolution of inflammation and tissue repair.
Chitohexaose Blocks Endotoxemia through TLR4
PLoS Pathogens | www.plospathogens.org 2 May 2012 | Volume 8 | Issue 5 | e1002717Figure 1. FAg/AgW binds to both human monocytes and murine bone marrow macrophages. (A) Human PBMCs were incubated with
biotinylated FAg followed by staining with Streptavidin-PE and CD14 FITC. Streptavidin-PE as conjugate control and FITC coupled antibodies as
isotype control were used. The representative dots present in the upper right quadrant represent the CD14+ve monocytes bind to biotinylated FAg.
(B) Human PBMCs were incubated with biotinylated FAg with and without unlabeled FAg followed by staining with Streptavidin-FITC and analysed
by FACS. Streptavidin-FITC was used as conjugate control. Representative overlaid histograms shows binding of labeled FAg are inhibited by
unlabeled FAg. (C,D) Binding of labelled FAg of S. digitata and B. pahangi to human monocytes and murine bone marrow macrophages. Human
PBMCs and murine (BALB/c) bone marrow macrophages were incubated with biotinylated FAg of S.digitata or B.pahangi or C.elegans for 30 minutes
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IL-10 levels (Figure 5B). More critically, chtx significantly blocked
LPS induced mortality of C57BL/6 mice (Figure 5C) suggesting
that it can be used as a potential antagonist to block adverse
biological consequences of endotoxemia in vivo. Administration of
chtx 6, 24 and 48 hrs after onset of endotoxemia was also effective
in blocking mortality of mice suggesting its potential as a
therapeutic agent (Figure 5 D). BALB/c mice which are more
susceptible to LPS induced endotoxemia than C57BL/6 mice
were also protected by chtx (Figure 5E).
Chtx induces alternate activation of monocytes/
macrophages in vitro
Alternate activation of macrophages has been well documented
in helminth infections [27]. Presence of abundant chitin in
helminthes [28] and activation of chitinase family proteins like
AMCase, Ym-1 and chitinase-3 during helminth infections [29]
suggests that chitin breakdown products from helminthes could be
responsible for alternate activation of macrophages. We explored
this possibility by stimulating human PBMCs and murine BMDM
with chtx. Ym-1, Arginase-1 and IL-10 (Figure 6 A–D, Figure S 4)
were up-regulated by murine BMDM upon stimulation with chtx.
Similarly, human monocytes released IL-10 (Figure 6 E) and up-
regulated intracellular Arginase activity confirming induction of
alternate activation of mononuclear cells by chtx in vitro (Figure 6
D,E).
Chtx induces alternate activation of macrophages in vivo
The potential of chtx to induce alternate activation of
macrophages in vivo was also addressed. BALB/c mice were
intraperitoneally administered with chtx or LPS and after
90 minutes the peritoneal cells were harvested and expression of
Ym-1 and Arginase-1 in CD14+ve cells were analyzed. Chtx up
regulate both Ym-1 and Arginase-1 while such an up-regulation
was not observed in LPS administered mice peritoneal macro-
phages (Figure S 4 G,H). Further, in vivo alternate activation of
macrophages by chtx even after onset of endotoxemia was
demonstrated. Up-regulation of Ym-1 and Arginase-1 was
observed in peritoneal macrophages collected 90 minutes post
chtx administration in mice with ongoing endotoxemia. It was
observed that chtx induce alternate activation of macrophages
even after onset of endotoxemia (Figure 6 F,G).
Alternate activation of macrophages induced by chtx is
mediated by TLR4
Chitin and chitin breakdown fragments have been reported
extensively to activate macrophages but the pathway of activation
and receptors involved remain contradictory [30]. The above
described results suggested that chtx activates macrophages
through alternate pathway using TLR4. We sought direct
biological proof by stimulating BMDMs of C3H/HeJ (TLR4
mutant mice) [31] and C3H/OuJ (wild type mice) with chtx and
LPS and canonical markers of both alternate as well as classical
macrophage activation were scored. As expected, LPS induced
release of inflammatory cytokines by BMDMs of wild type mice
and not by cells of mutant C3H/HeJ mice (Figure 7 A,B). Chtx on
the other hand failed to induce classical activation markers viz;
TNF-a, IL-1b and nitrite (Figure 7 A,B) but up-regulated
expression of alternate activation markers viz; Ym-1 (Figure 7
C,E) and Arginase-1 (Figure 7 D,F) in wild type mice and not in
mutant mice. From these observations we make two broad
conclusions: a) classical and alternate macrophage activation could
be mediated using the same receptor, TLR4 by LPS and chtx
respectively and b) the mutation in TLR4 gene that results in
substitution of proline to histidine in its intracellular domain [32]
plays a critical role in both classical as well as alternate activation
pathways in macrophages.
Monocytes in filariasis infected subjects display alternate
activation phenotype and are LPS resistant
Finally we addressed the significance of these observations in
human lymphatic filariasis. The expression of TLR4 was
significantly low on monocytes of infected subjects positive for
CFA (Circulating Filarial Antigen) in comparison to endemic
controls (negative for CFA ) (Figure 8A). Binding of labeled FAg to
monocytes was also significantly less in infected subjects in
comparison to endemic controls (Figure 8B,C) however when
monocytes of infected subjects were incubated in vitro at 37uC for
4 hrs binding of labeled FAg as well as expression of TLR4 were
comparable to endemic controls (Figure 8D,E). We interpret these
findings to imply that circulating filarial antigens saturate TLR4
on monocytes which get recycled when incubated in culture thus
exposing surface TLR4 to bind FAg or to react with anti-TLR4
(Figure 8E). Further, LPS induced inflammatory molecules by
PBMCs of infected subjects was significantly decreased in
comparison to controls as shown by TNF-a, IL-1b and IL-6
(Figure S 5A–C) levels in culture supernatants suggesting that
monocytes of subjects with filarial infections are less prone for
activation by LPS possibly due to saturation of TLR4 with
circulating filarial antigens. This issue was further addressed by
incubating monocytes of infected individuals with heterologous
(negative for CFA) normal plasma and FBS and stimulated with
LPS or with LPS+FAg and inflammatory molecules like TNF-a,
IL-1b and IL-6 were quantified in culture supernatants. LPS
induced inflammatory cytokines by monocytes of infected
individuals are comparable with monocytes of endemic controls
when incubated with normal heterologous plasma or with FBS
suggesting that filarial antigen in infected plasma saturate TLR4
on monocytes thus blocking activation by LPS (Figure 8 F,G,H).
Expression of CD23, CD163, and CD206 canonical markers of
alternate macrophage activation [33] were significantly up-
regulated on circulating monocytes of infected subjects in
comparison to uninfected controls (Figure 8 A).
Discussion
Three novel issues stand out from the results being reported in
this communication-a) that a small molecular weight carbohy-
drate, chtx activates macrophages to a non-inflammatory pheno-
type through TLR4 and in doing so functions as an LPS
antagonist and blocks induction of inflammatory mediators by
LPS in vitro (both in murine macrophages and in human
monocytes) and endotoxemia in vivo, b) that two diverse pathways
of activation of macrophages could be operational by two different
at 4uC followed by staining with Streptavidin-FITC and analysed by FACS. Binding to monocyte as well as lymphocyte gated populations is shown.
Binding of FAg (S.digitata ; N=34) and FAg (B.pahangi, C.elegans- N=5) are shown for human monocytes whereas N=10 for FAg of S.digitata and
B.pahangi and N=5 for FAg of C.elegans are shown for murine bone marrow macrophages. (E, F) Human PBMCs and Mouse bone marrow cells were
incubated with biotinylated FAg or biotinylated AgW at 4uC for 30 minutes and stained with Streptavidin-PE and analyzed by FACS. Representative
overlaid histograms shows binding of FAg, AgW to human CD 14+ve cells (E) and murine bone marrow cells (F).
doi:10.1371/journal.ppat.1002717.g001
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PLoS Pathogens | www.plospathogens.org 4 May 2012 | Volume 8 | Issue 5 | e1002717Figure 2. Binding OF FAg/AgW to human monocytes (in PBMCs) or murine macrophages (in BMDM) is mediated through TLR4.
(A,B) BonemarrowcellsofBALB/c mice(A) orpurifiedhumanPBMCs(B)were incubatedwithanti-mouseTLR4-PEandanti-human TLR4-PErespectively
in the presence or absence of AgW at 4uC for 30 minutes, and CD 14
+ cells analyzed by FACS. Representative overlaid histogram shows competitive
inhibitionofbindingofanti-mouseantibodies (A) or anti-human antibodies (B) toTLR4.(C) Soluble TLR4directly bindstothe helminthicantigens. ELISA
plates were coated with solubilised extracts of S.digitata, AgW, N.brasiliensis, H.polygyrus, C.elegans and mock-BSA, Phosphorylcholine-BSA, GlcNAc-BSA,
Mannose-BSA andLPS. After blocking with skimmed milk-PBS, human PBMC lysates were incubated. The plates were washed and incubated with rabbit
anti-human TLR4 antibodies and their binding was detected by using peroxidase conjugated anti-rabbit IgG. The enzyme activity was measured using
OPD. % mean 6 SEM of two individual experiments are shown. (D) Jurkat cells trasfected with mock or TLR4 plasmid were incubated with anti-human
TLR4-PE and analysed by FACS. Representative overlaid histogram shows enhanced expression of TLR4 by transfected cells as compared to mock
transfectedcells.(E) Enhanced bindingto FAgafter over expression of TLR4. Mock or TLR4 transfectedjurkatcells were incubated with biotinylated FAg
at 4uC for 30 minutes and stained with Streptavidin-PE conjugate. The cells were thoroughly washed to remove unbound Streptavidin-PE and analysed
by FACS. Representative overlaid histogram shows enhanced binding of FAg to transfected cells as compared to mock transfected cells.
doi:10.1371/journal.ppat.1002717.g002
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cell and finally c) that glycoproteins of filarial nematodes with chtx
as a constituent could be saturating TLR4 on circulating
monocytes in infected subjects rendering them refractory to LPS
induced inflammatory activation.
We have provided evidence for direct binding of AgW to TLR4
by flow cytometry and consequent activation of alternate pathway
of monocytes/macrophages. We have also shown by in silico
analysis and solid phase immunoassay that chtx also binds toTLR4
and that the phenotype of activation pathway by chtx is similar to
that of AgW. It is critical to note that unlike AgW, native LPS does
not bind to TLR4 - several investigators have provided convincing
evidence to suggest that native LPS does not bind directly to
TLR4 but it activates macrophages by forming a complex with
LPS binding protein (LBP) and CD14 and this complex delivers
LPS to MD2 which activates macrophages through TLR4 [9–11].
When viewed in this context our findings on direct binding of
AgW to TLR4 and activation of macrophages by alternate
pathway is fundamentally different from macrophage activation by
LPS which does so without directly binding to TLR4 in its native
form.
Benefits of inhibition of TLR4 activation has been documented
in several experimental models of lethal shock. Anti-CD14
antibodies in rabbits, primates and humans [34–36], anti-TLR2
antibodies [37] and antibodies to TLR4 [15] or TLR4/MD2
complex [17] have been tested with a high degree of success.
Synthetic LPS antagonists such as Eritoran and Tak-242 have
been tested in experimental models of endotoxic shock and also in
human disease [19] but Eritoran has been recently reported to be
ineffective in phase-III clinical trial (http://clinicaltrials.
pharmaceutical-business-review.com/news/eisai-eritoran-fails-to-
meet-primary-endpoint-in-phase-iii-trial-250111). Molecules in-
volved in downstream signaling of TLR such as platelet-activating
factor [38] oxidized phospholipids [22,23], nitrate salts [20], 5c
[21] have also been tested with a degree of success. Potential of
antibodies to TNF-a, IL-1RA, TNF-a soluble receptors and anti-
bradykinin have also tested [39] but it has been observed that
treatment with such TLR inhibitors interfere with innate
immunity of host against infection and consequently increasing
the risk of shock and mortality [39,40,41]. In this context the
results of this study offers significant promise- a non immunogenic
inexpensive small molecular weight chito-oligosaccharide can be
used as an LPS antagonist. Based on in vitro demonstration of
alternate activation of murine macrophages and human mono-
cytes and in vivo activation of murine macrophages into alternate
phenotype by chtx leading to inhibition of LPS mediated
induction of inflammatory molecules (such as IL1b, TNF-a, IL-6
etc) by chtx we conclude that the small molecular weight
carbohydrate induces alternate activation of macrophages in vivo
and mediates protection against endotoxemia. Thus Chtx appears
to protect against endotoxemia by two mechanisms - a) it
competitively inhibits LPS induced activation by binding to
TLR4 and/or b) it activates macrophages by alternate anti-
inflammatory pathway. Generation of such an activation appears
to have many advantages since alternately activated macrophages
are reported to be endotoxin resistant [42,43] with increased
phagocytic activity [44] and enhanced expression of scavenger
receptors and proangiogenic factors [45] make them assist in tissue
repair and resolution of inflammation [46]. We are currently
testing if monocytes of sepsis patients can be re-programmed to
non-inflammatory state by chtx.
LNFP-III a complex carbohydrate moiety of S.mansoni, thior-
edoxin peroxidase of F.hepatica and migration inhibition factor
(MIF) of B.malayi [47,48] are other molecules of helminth origin
reported to induce alternate activation of macrophages but the
host receptor through which such activation is mediated is still
largely unknown. The current study demonstrating the role of
TLR4 in chtx induced alternate activation of macrophages has
offered insights into the issue of induction of alternate activation by
helminth products. Although there have been many studies
examining TLR signaling in response to pathogens [49–51] fewer
studies have examined interaction of multicellular helminth
parasites with TLRs on monocytes or macrophages. Helminth
products such as excretory secretory (ES) product of Necator
americana or OV-Asp-1 of Onchocerca volvulus [52,53] are known to
interact with cells of the innate immune system but the receptor
associated with this interaction has not been elucidated. In the
present study a filarial glycoprotein designated as AgW has been
demonstrated to bind directly to TLR4. These results are in broad
agreement with demonstration of ES-62, a filarial glycoprotein
interacting with TLR4 [24]. Apart from identifying TLR4 as a
receptor for a helminth carbohydrate, the current study will be of
crucial interest to cell biologists since TLR4 appears to function as
a common receptor for both classical as well as alternate activation
of macrophages and the nature of ligand determining the
phenotype. This clearly offers scope for acquiring insights into
molecular events involved in mutually exclusive activation
pathways of macrophages.
Human filariasis is characterized by chronic persistence of
circulating filarial antigens (CFA) for several years. TLR4 on
monocytes in infected subjects appear to be saturated in vivo with
CFA since labeled FAg bound poorly bound to monocytes ex vivo
and normal binding of FAg to TLR4 could be achieved by
allowing antigen saturated TLR4s to recycle in vitro. The findings
reported here suggest that CFA in plasma seem to remain bound
to TLR4 on monocyte surface in infected subjects and contribute
to sustenance of their alternate activated state. The following
observations indicate that inherent defect in monocytes of infected
subjects do not contribute to their failure to get activated by LPS:
1. Monocytes of infected subjects when incubated with infected
(autologous) plasma, the response to LPS was significantly
diminished (as shown by decreased TNF-a, IL-1b and IL-6 levels
in culture supernatants) when compared with response of same
monocytes incubated with FBS or normal plasma; 2. Monocytes of
Figure 3. The binding of FAg to TLR4 is mediated by carbohydrate residues. Binding of AgW to human peripheral monocytes is inhibited
by penta and hexa Chitooligosaccharides. (A) Human PBMCs were incubated with biotinylated AgW in the presence or absence of chitosugars viz;
chitobiose, chitotriose, chitotetrose, chitopentaose and chtitohexaose followed by staining with Streptavidin FITC and CD14
+ cells were analysed by
FACS. % mean 6 SEM of six experiments are shown. * P,0.001, versus AgW binding without chitosugars (Student’s t-test). (B) Binding of AgW to
TLR4 is inhibited by chtx. ELISA plates were coated with AgW. After blocking with skimmed milk-PBS, human PBMC lysate were pre incubated with
different concentrations of chtx for 30 minutes at 37uC and were then transferred to AgW coated plates. Cell lysates without pre incubation with chtx
was used as control. The plates were thoroughly washed and were incubated with rabbit anti-human TLR4 and its binding was detected by using
peroxidase conjugated anti-rabbit IgG. The enzyme activity was measured using OPD as substrate. % mean 6 SEM of two experiments are
shown * P,0.001, versus cell lysates without preincubated with chtx (Student’s t-test). (C) In silico analysis between chtx and TLR4. Three dimensional
molecular docking between chtx and extra cellular domain of mouse TLR4 was performed using patch dock software demonstrating the interaction
of chtx to the internal pocket of extra cellular domain of TLR4.
doi:10.1371/journal.ppat.1002717.g003
Chitohexaose Blocks Endotoxemia through TLR4
PLoS Pathogens | www.plospathogens.org 7 May 2012 | Volume 8 | Issue 5 | e1002717Chitohexaose Blocks Endotoxemia through TLR4
PLoS Pathogens | www.plospathogens.org 8 May 2012 | Volume 8 | Issue 5 | e1002717infected subjects cultured with normal plasma respond poorly to
LPS when FAg was added exogenously; 3. FAg significantly
inhibited release of TNF-a, IL-1b and IL-6 by normal monocytes
when cultured with autologous plasma and stimulated with LPS; 4.
When monocytes of infected subjects are incubated with FBS or
with normal human plasma, the cells get activated well to LPS as
shown by higher levels of inflammatory cytokines in supernatants -
TNF-a, IL-1b and IL-6 levels are comparable to those observed in
normal monocyte cultured with normal (autologous) plasma .
While our observations that circulating monocytes in filariasis
infected subjects display alternate activation markers are similar to
an earlier report [54] diminished induction of mediators of
inflammation such as TNF-a, IL-1b and IL-6 by LPS treated
monocytes of filariasis infected subjects is a novel observation. The
possibility that subjects with filarial infections will be regulating
hyper inflammation associated with bacterial infections and thus
offering protection against endotoxemia associated with sepsis
needs further investigation. These findings also suggest interesting
evolutionary issues on co-infection of humans with nematodes and
gram negative bacteria and their pathogenesis. It is tempting to
propose that increasing incidence of sepsis/septic shock in
developed countries over the last 100 years (2) could have been
due to eradication of helminth infections, a scenario similar to
increased incidence of allergies and autoimmune diseases in
developed countries as a consequence of elimination of infectious
disease as proposed in ‘Hygiene Hypothesis’.
Materials and Methods
Ethics statement
Institutional Animal Ethics Committee of Institute of Life
Sciences ‘‘approved’’ all the protocols followed for experiments
conducted using mice. The study was carried out in strict
accordance with the recommendations of the Committee for
Prevention of Cruelty and safety of experiments with animals
(CPCSEA) a regulatory body of Government of India that
supervises Care and Use of Laboratory experimentation through
their nominees in the Institutional animal ethics committee. Adult
Setaria digitata worms from peritoneal cavities were collected from
the abattoir attached to a local zoo after obtaining approval from
zoo authorities. The animals are slaughtered in the abattoir
regularly for feeding wild cats and no animals were slaughtered
specifically for the purpose of our study. The study on human
filariasis was approved by Institutional Human Ethics Committee
of Institute of Life Sciences which operates under the guidance of
regulations of Indian Council of Medical Research. Written
informed consents were obtained from each of the normal control
volunteers, filariasis infected persons and/or their legal guardians
before collection of blood samples.
Collection of bovine adult filarial parasites (S.digitata)
Peritoneal dwelling adult female filarial parasites (Setaria digitata)
were collected from cattle in a local abattoir, attached to the local
zoological park at Nandankanan, Bhubaneswar after obtaining
necessary approval from zoo authorities. The worms were
transported to the laboratory in Dolbecco’s Modified Eagles
Medium (DMEM) (Sigma) pH 7.00 containing antibiotics [Pen-
icillin Streptomycin solution 1 ml/100 ml of medium] (Sigma) and
1% glucose (Hi-media).
Preparation of filarial extracts and labeling
Aqueous extracts of S. digitata (designated as FAg) was prepared
by homogenization followed by ultrasonication and the aqueous
extract of adult worms was biotinylated using appropriate
derivatives of biotin i.e. N-hydroxysuccinamide derivatives (Sigma)
suitable for protein labeling.
Preparation of AgW
One milligram of FAg was passed through WGA-Sepharose
(Sigma) coloumn and the unbound proteins were washed by
passing PBS and glycoproteins bound to WGA were eluted by
Glycine-HCl buffer (pH 3.6).The pH of the elutes was adjusted
using 0.1 M NaOH and dialysed against PBS. Protein concentra-
tion of the elute was estimated and stored at 220uC for further
use.
LAL Assay. Batches of purified AgW and FAg were tested by
LAL assay for absence of endotoxin as per the manufactures
instruction using commercially available LAL assay kit (MP
Biomedicals) and endotoxin free water was used for diluting both
AgW and chtx before use in cell culture.
Animals
BALB/c, C57BL/6, C3H/OuJ and C3H/HeJ mice were
obtained from National Institute of Immunology, New Delhi
which was originally imported from Jackson laboratories,
Germany. Breeding and maintenance were done at the animal
facility at Institute of Life Sciences, Bhubaneswar, India. 8–10
weeks old animals were used for this study. Institutional animal
ethics committee of Institute of Life Sciences, Bhubaneswar
approval was obtained for all the investigations conducted in mice.
Bone marrow cells culture
Mouse bone marrow cells were collected from femoral shafts by
flushing with 3 ml. of cold sterile DMEM (Sigma) supplemented
with 20 mM of L-Glutamine (ICN), antibiotics (1 ml penicillin and
streptomycin/100 ml of medium) (Sigma)containing 10% FBS.
The cell suspension was passed through a sieve to remove large
clumps. The cell suspension was washed 2–3 times with sterile
DMEM and adjusted to 0.5610
6 cells/well and cultured in 24 well
plates. After 8–10 hrs incubation at 37uC non adherent cells were
removed by washing with sterile DMEM and the adherent cells
(more than 96% positive for CD14 (Figure S-4 and S-6 indicating
high purity) were stimulated with LPS (Sigma, 055:B5 L-2880)
with or without FAg or chtx (Dextra Lab) at 10 mg/ml
concentration. After 48 hrs the supernatants were aspirated,
frozen at 280uc and used later for estimation of cytokine levels.
The adherent cells were removed using chilled medium and
Figure 4. Chtx or FAg inhibits LPS induced inflammation. Human monocytes and BMDM of BALB/c mice were stimulated with FAg, chtx with
and without LPS for 48 hrs. TNF-a, IL-1b, Il-6 and nitrite in culture supernatants were quantified according to the manufacturer’s instruction. TNF-a, IL-
1b, IL-6 and nitrite in culture supernatants for mice (Fig. 4A,B,C) and TNF-a, IL-1b and IL-6 in human (Fig. 4 D,E) are shown * P,0.001, versus LPS
treated cells (Student’s t-test). N=21 for human control, LPS, FAg, LPS+FAg and for chtx and chtx+LPS N=10. N=15 for mouse control, LPS, FAg,
LPS+FAg and for chtx and chtx +LPS N=10. (F) LPS induces significant increase of proinflammatory mediators in comparison to chtx as shown by RT-
qPCR. Bone marrow derived macrophages were treated with LPS and chtx for 6 hrs. The cells were harvested and total RNA were isolated from the
cells. Expression of TNF-a, IL-1b, IL-6 and iNOS genes was analysed. (G) Cultured BMDM of BALB/c mice were pre incubated with 5 mMH 2-DCFDA
before treatment with LPS, chtx or mixture of both. The cells were harvested after 24 hrs, washed with PBS twice and analysed by FACS.
Representative histogram shows generation of ROS by LPS and their inhibition by chtx.
doi:10.1371/journal.ppat.1002717.g004
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PLoS Pathogens | www.plospathogens.org 9 May 2012 | Volume 8 | Issue 5 | e1002717Figure 5. Chtx protects mice from endotoxic shock. Chtx and FAg inhibit induction of pro inflammatory cytokines in vivo by LPS. Eight to ten
weeks old BALB/c mice were injected IP with 15 mg/Kg body wt of LPS with or without FAg (100 mg) and chtx 250 mg and blood was collected by
heart puncture in heparinised tubes after 2 hrs. Plasma levels of TNF-a, IL-1 b and IL- 6 (Fig. 5 A) and IL-10 and nitrite (Fig. 5 B) were quantified as
described earlier. Mean 6 SEM of 10 independent experiments are shown. * P,0.001, versus LPS treated cells (Student’s t-test). (C) C57 BL/6 mice
were injected IP with lethal dose of LPS (60 mg/Kg body wt) with or without chtx (250 ug) and mortality was scored. (N=15). (D) C57 BL/6 mice were
injected IP with lethal dose of LPS (60 mg/Kg body wt) and chtx was injected later as shown and mortality scored. N=17 for LPS, N=10 for LPS+Chtx
6 hrs, N=16 for LPS+Chtx 24 hrs and LPS+chtx 48 hrs. (E) BALB/c mice were injected IP with lethal dose of LPS (15 mg/Kg body wt.) with or without
FAg (100 mg) or AgW (50 mg) or Chtx (250 mg) and the mortality was scored. N=10.
doi:10.1371/journal.ppat.1002717.g005
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PLoS Pathogens | www.plospathogens.org 10 May 2012 | Volume 8 | Issue 5 | e1002717Figure 6. FAg or chtx induce alternate activation of both human monocytes and murine macrophages. Human monocytes and BMDM
of BALB/c mice were stimulated with FAg, chtx or LPS for 48 hrs. IL-10 in culture supernatants were quantified according to the manufacturer’s
instruction. Both human and mice cells were analysed for Arginase activity and additionally mice cells were analysed for Ym-1 and Arginase-1 by
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PLoS Pathogens | www.plospathogens.org 11 May 2012 | Volume 8 | Issue 5 | e1002717analysed for intracellular Arginase activity by calorimetric assay
and intracellular staining using antibodies to Ym-1 and Arginase-1
staining and scored by flowcytometry.
Mouse model of Endotoxemia
8–10 weeks old BALB/c and C57BL/6 mice were intraperito-
neally injected with 15 mg/Kg body wt and 60 mg/Kg body wt.
of LPS respectively with and without FAg (100 mg) or AgW (50 mg)
or chtx (250 mg) and observed for mortality a period over 168 hrs.
These doses were determined by prior titration and the lowest
concentration effective in vivo was chosen for experimentation.
For analysis of levels of cytokines mice were sacrificed 2 hrs after
challenge with LPS or LPS with FAg (100 mg) or LPS with
chitohexaose (250 mg). Blood was collected in heparinised tubes by
heart puncture and clear plasma was isolated by centrifugation at
5000 g for 10 minutes and analysed for presence of TNF-a, IL-1b,
nitrite and IL-10 as described below.
Human blood samples. The study population was drawn
from areas in and around Bhubaneswar, Orissa; highly endemic
for Bancroftian filariasis. About 5 ml. of nocturnal blood each was
collected in heparinised glass vials from the selected human study
population as per the ethical guidelines of ILS, Bhubaneswar,
Orissa. The patients were classified into different clinical
categories according to the criteria described by our group earlier
[55]. Subjects with active filarial infection were identified as
described and blood samples were collected from subjects with
circulating filarial Antigen (CFA) positive and those free of
infection for this study. The study on human filariasis was
approved by Institutional Ethics Committee of ILS and written
consents were obtained from normal as well as infected persons
before collection of blood samples.
Isolation of human PBMCs and in vitro culture
Human PBMCs were isolated from heparinised venous blood
samples by density gradient centrifugation method using Histopa-
que (Sigma). Briefly, the heparinised blood was layered on LSM
medium gently in the ratio of 1:1 and subjected to centrifugation
at 100 g for 30 minutes. The white layer representing PBMCs was
aspirated out gently and transferred aseptically into sterile
centrifuge tubes. The suspension of cells was then washed and
cultured in sterile DMEM supplemented with 20 mM of L-
Glutamine (ICN), 10% of autologus plasma/FBS and antibiotics
(1 ml penicillin and streptomycin/100 ml of medium) (Sigma).The
no. of cells was adjusted 0.5610
6 cells/well in 24 well plates. After
8–10 hrs incubation at 37uC non adherent cells were removed by
flushing with sterile DMEM and the adherent cells were
stimulated with LPS, FAg or chtx, LPS along with FAg and LPS
along with chtx at 10 mg/ml concentration for 48 hrs. after which
the supernatants were removed and used for cytokine estimation.
The adherent cells were removed and analyzed for intracellular
Arginase activity by calorimetric assay as described below.
For study of recycling of the receptor, the PBMCs were
resuspended in DMEM containing 0.1% BSA and incubated at
37uC for 4 hrs. Then cells were incubated with biotinylated FAg at
4uC for 30 minutes followed by staining with streptavidin-FITC
and analyzed by FACS.
Quantification of cytokines
Supernatants from human monocytes or mouse BMDM
cultures as well as mice plasma samples were analysed for levels
of TNF-a, IL-1b, IL-6 and IL-10 by a sandwich ELISA according
to manufacturers instruction using commercially available ELISA
kits (e-Biosciences).
Flow cytometry
Human PBMCs or mouse BMDM (1610
6/ml) were stained for
30 minutes at 4uC with fluorescence labeled antibodies specific to
CD14, TLR4 (e Biosciences) mixed with and without FAg or AgW
along with relevant isotype controls. Human cells were also stained
with antibodies to CD23, CD163, and CD206 (Santacruz
Biotech.).The cells were thoroughly washed to remove the
unbound antibodies and analysed by FACS (BD FACS caliber).
For intracellular Arginase-1 and YM-1 staining, cells were
permeabilised with 16 FACS permeabilising solution (BD
biosciences) and then incubated with rabbit antibodies to mouse
YM-1 (Stemcell technologies) or goat anti-mouse Arginase-1
antibodies (Santacruz Biotech.) followed by staining with anti-
rabbit IgG-FITC(Sigma) and anti-goat IgG-PE (Santacruz Bio-
tech.) respectively and analysed by FACS. Appropriate isotype
controls/conjugate controls were used for all flowcytometric
assays.
Preparation of PBMC and bone marrow cell lysates
Human PBMCs or mouse (BALB/c) bone marrow cells (2610
6)
were incubated with 2 ml of cell lysis solution (Sigma) and a
cocktail of protease inhibitors (Sigma) for one hr. at 4uC and then
ultra-sonicated. The supernatant was collected by centrifuging at
1500 g for 10 minutes and stored for further use.
Enzyme Linked Immunosorbent Assay
ELISA plates (Nunc maxisorp) were coated with 1 mg of PBS
extracts of S.digitata, AgW, N.brasiliensis, H.polygyrus or mock BSA,
Phosphorylcholine coupled to BSA, GlcNaC-BSA, Mannose-BSA
or LPS. After blocking with 1% skimmed milk-PBS (Hi-media),
human PBMC lysates or mouse (BALB/c) bone marrow cell
lysates were incubated for 2 hr at 37uC.The plate was thoroughly
washed and were incubated with rabbit anti-human and rabbit
anti-mouse TLR4 (e Biosciences) respectively. The binding of anti-
human and anti-mouse TLR4 was detected by using peroxidase
conjugated anti-rabbit IgG (Sigma). The enzyme activity was
measured using OPD (Sigma).
Detection of intra cellular ROS (REACTIVE OXYGEN
SPECIES)
The intracellular accumulation of ROS was determined using
the fluorescent probe (2, 7, Dichloro Dihydro Fluorescein
Diacetate) H2-DCFDA as described previously [56].
Nitrite analysis and Arginase assay
Nitrite level in culture supernatants of BMDM and intracellular
Arginase activity of both human monocytes and BMDM lysates
were quantified as described elsewhere [57]. Arginase activity was
measured in cell lysates. Briefly, cells were lysed using 50 mlo f
intracellular staining. (A,B,C) Expression of Ym-1 and Arginase-1 in mouse BMDM upon stimulation with FAg and chtx (N=10). (D) Induction of IL-10
and up-regulation of Arginase activity in BMDM upon stimulation with FAg and Chtx (N=10). (E) Induction of IL-10 (N=21 for basal, LPS, FAg and 10
for chtx) and up-regulation of Arginase activity in human PBMCs upon stimulation with FAg and chtx (n=10). LPS failed to induce IL-10, Arginase-1
and Ym-1 (C,D,E). * P,0.001, versus LPS treated cells (Student’s t-test). (F, G) Expression of Ym-1 and Arginase-1 by peritoneal macrophages analyzed
ex-vivo after administration of LPS at time 0 and chtx at time 6 hrs. Peritoneal macrophages collected 90 minutes post chtx administration were
stained for Ym-1 or Arginase-1 were analysed.
doi:10.1371/journal.ppat.1002717.g006
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PLoS Pathogens | www.plospathogens.org 12 May 2012 | Volume 8 | Issue 5 | e1002717Figure 7. Alternate activation of macrophages induced by chtx is mediated by TLR4. Bone marrow cells of C3H/HeJ and C3H/OuJ were
stimulated with LPS, chtx or FAg for 48 hrs. (A,B)TNF-a, IL-1 b and nitrite levels in culture supernatants were quantified. % mean 6 SEM of three
experiments are shown * P,0.001, versus C3H/OuJ cells (Student’s t-test). (C–F) Role of TLR4 in activation of macrophages differentially by LPS and
chtx. BMDM of C3H/HeJ and C3H/OuJ mice were stimulated with FAg, LPS and chtx for 48 hrs. Intracellular expression of YM-1 and Arginase-1 was
scored. Representative overlaid histogram shows the up regulation of Ym-1 and Arginase-1 upon stimulation with FAg, chtx only in wild type C3H/
OuJ mice (D,F) and not inC3H/HeJ (C,E) whereas LPS fail to up-regulate Ym-1 and Arginase-1 expression in both the strain of mice. % mean 6 SEM of
five individual experiments for Ym-1 (G) and Arginase-1 (H) are shown.
doi:10.1371/journal.ppat.1002717.g007
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PLoS Pathogens | www.plospathogens.org 13 May 2012 | Volume 8 | Issue 5 | e1002717Figure 8. Monocytes of subjects with active filarial infection are alternately activated and less responsive to LPS induced signaling.
(A) PBMCs (suspended in medium containing autologous plasma) of subjects with active filarial infection and endemic controls were stained for TLR4
(N=10), CD23 (N=8), CD163 (N=11) and CD206 (N=10) along with CD14. Cells gated for CD14 were analysed by FACS. * P,0.001, versus CFA
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as protease inhibitors during lysis. This mixture was incubated for
30 min at room temperature. 50 ml of 10 mM MnCl2 and 50 mM
Tris-HCl were added to lysed cells to activate the enzyme by
heating for 10 min at 56uC. Then 25 ml of 0.5 M L-arginine,
pH 9.7 was added and incubated at 37uC for 45 min. The
reaction was stopped with 400 ml of H2SO4 (96%)/H3PO4
(85%)/H2O (1/3/7, v/v/v). 25 mlo fa-isonitrosopropiophenone
(dissolved in 100% ethanol) was added to the mixture followed by
heating at 95uC for 45 min and urea concentration was measured
at 540 nm.
Docking studies
The X-ray structure of the extracellular domain of TLR4 (PDB
code: 3FXI) [58] in complex with MD-2 is available. The X-ray
structure of the TLR4-MD-2 complex (3FXI) was downloaded
from the PDB data base. The TLR4 structure from this complex
was extracted and used for docking with chtx. The chemical
structure of chtx molecule was extracted from pubchem database
(http://pubchem.ncbi.nlm.nih.gov). Structure of the chtx was
retrieved into two-dimensional MDL/SDF format and three
dimensional coordinates were generated using the ACCELRYS
DS modelling 2.5 (Accelrys Inc. San Diego, CA 92121, USA)
software suite. The missing hydrogen of the structure was fixed
and subjected to energy minimization. All energy minimization
were carried out using the conjugate gradient method of CHARM
force field using the ACCELRYS DS modelling 2.5 (Accelrys Inc.
San Diego, CA 92121, USA) software suite.
Docking studies were carried out using Genetic Optimization for
Ligand Docking (GOLD) software, version 4.1.1 (Cambridge
Crystallographic Data Centre, Cambridge, UK). The number of
run was set to 100 in the standard default settings. The standard
default settings,consisting ofpopulationsize-100,selectionpressure-
1.1, niche size-2, migrate-10, cross over-95, number of operations-
1,00,000 number of docking 10 were adopted for GOLD docking.
For ligand- protein binding, 10 docking conformations (poses) were
tested and the best GOLD score were considered for further
analysis. The ligand showing maximum interactions with the
protein were plotted using the program LIGPLOT. The active site
was predicted by using Q-site finder [59].
RNA isolation, reverse transcription and quantitative real
time (QRT) PCR analysis
Total RNA was isolated from stimulated cells using RNAeasy
columns from Qiagen, as per the manufacturer’s instructions. 1 mg
of total RNA from each sample was treated with DNAse I
(Ambion Inc.). Synthesis of cDNA was performed by using First
Strand Synthesis kit and the Superscript III Reverse Transcriptase
(Invitrogen), according to the manufacturer’s instructions. All real-
time PCR experiments were performed in ABI prism 7900 HT
sequence detection system (ABI) as described earlier [60]. The
PCR conditions were as follows: 95uC for 10 min, 95uC for 15 sec,
58uC for 30 sec and 72uC for 30 sec for 40 cycles. The primers
used for each gene are listed in (Table S 1). Primers were used at a
concentration between 1 and 5 pmoles per reaction. All the
reactions were analyzed using the software (SDS 2.3) provided
with the instrument. The relative expression of the genes was
calculated by using 2-DDCt formula using GAPDH as a
normalizer. The values reported are the mean of two biological
replicates. The standard deviation from the mean is shown as error
bars in each group.
Statistical analysis
Statistical significance among experimental groups was analyzed
by the unpaired Student’s t-test using Graph pad prism software
(Prism-5).
Supporting Information
Figure S1 A Glycoprotein fraction (AgW) purified from
FAg binds to human monocytes. Biotinylated FAg was passed
through a WGA-sepharose affinity purification coloumn according
to manufactures instructions. Both bound and unbound fractions
were collected. Human PBMCs were incubated with both native,
unbound (1
st elute) and bound (2
nd elute i.e. AgW) fractions
followed by staining with Streptavidin FITC and the cells gated for
monocytes were analyzed by FACS (A). N=5. Bone marrow cells
and human PBMCs were incubated with anti-mouse TLR4 PE (B)
or anti- human TLR4 PE (D) respectively with and without FAg at
4uC for 30 minutes and analyzed by FACS. B- Representative
overlaid histogram shows binding of anti-mouse TLR4 to CD
14+ve cells and competitive inhibition by FAg or AgW. D-
Representative overlaid histogram shows binding of anti-human
TLR4 to CD 14+ve cells and competitive inhibition by FAg. The
monocyte or macrophage population binding to FAg was
considered. % mean6 SEM of five individual experiments
performed with murine bone marrow cells and human PBMCs
are also shown (Figures S.1C and S.1E respectively). * P,0.005,
versus anti-TLR4 stained cells (Student’s t-test). (F) Soluble TLR4
directly binds to the helminthic antigens ELISA plates were coated
with (1 ug in PBS) extracts of S.digitata, AgW, N.bracilliences,
H.polygyrus, C.elegans, mock BSA, PC-BSA, GlcNAc-BSA, Man-
nose-BSA or LPS. After blocking with 1% skimmed milk-PBS,
lysates of mouse bone marrow cells were incubated for 2 hr at
37uC. The plates were thoroughly washed and were incubated
with anti-mouse TLR4 and bound antibody was detected using
peroxidase conjugated anti-rabbit IgG. The enzyme activity was
measured using OPD. % mean 6 SEM of two individual
experiments are shown.
(TIF)
Figure S2 Binding OF AgW to monocytes or macro-
phages is mediated through TLR4. Bone marrow cells of
(Circulating Filarial Antigen)2ve cells (Student’s t-test). (B) PBMCs (suspended in medium without autologous plasma) of subjects with active filarial
infection and endemic controls were incubated with biotinylated FAg at 4uC for 30 minutes followed by staining with Streptavidin-FITC and analysed
by FACS. Representative overlaid histogram shows binding of FAg to monocytes of subjects with active filarial infection and endemic control. (C)
Same as 8B but performed in 12 subjects with active filarial infection and 34 endemic controls FAg. * p,0.001 versus endemic controls. (D) PBMCs of
subjects with filarial infection (CFA+ve) were incubated at 37uC for 4 hrs and then incubated with anti-human TLR4-PE and analysed by FACS. PBMCs
incubated at 4uC and stained with anti-TLR4 were taken for comparison. Representative overlaid histograms are shown for CD14+ve monocytes. (E)
PBMCs of 5 human subjects with filarial infection (CFA+ve) were incubated at 37uC for 4 hrs and then incubated with anti-human TLR4-PE or
biotinylated FAg at 4uC for 30 minutes followed by staining with streptavidin-FITC and CD14 gated population were analysed by FACS. PBMCs
incubated at 4uC were taken for comparison. (F,G,H) PBMCs of 10 human subjects with active filarial infection were cultured in medium containing
10% autologus/heterologous normal plasma or 10% FBS in humidified atmospheric condition (5% CO2, 80% humidity). After 8–10 hrs incubation at
37uC non adherent cells were removed by washing with sterile medium. The remaining adherent cells were stimulated with LPS or LPS along with
FAg for 48 hrs. The culture supernatants were analyzed for TNF-a (Fig. 8 F) and IL-1b (Fig. 8G) and IL-6 (Fig. 8H).
doi:10.1371/journal.ppat.1002717.g008
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PLoS Pathogens | www.plospathogens.org 15 May 2012 | Volume 8 | Issue 5 | e1002717BALB/c mice (A,B,C) or purified human PBMCs (D,E,F) were
incubated with anti-mouse TLR4-PE and anti-human TLR4-PE
respectively in the presence or absence of AgW at 4uC for
30 minutes, and CD 14
+ cells analyzed by FACS. Representative
dot plots show competitive inhibition of binding of anti-mouse
antibodies (A,B,C) or anti-human antibodies (D,E,F) to TLR4.
(TIF)
Figure S3 FAg interacts with TLR4 through carbohy-
drate residues. A,B - Chitinase treated FAg or deglycosylated
FAg fail to inhibit binding of Biotinylated FAg to human PBMCs.
Human PBMCs were incubated with biotinylated FAg with and
without chitinase treated FAg or sodium meta periodate treated
deglycosylated FAg or cold unlabelled FAg at 4uC for 30 minutes
followed by staining with Streptavidin-PE and cells gated for
monocytes were analyzed by FACS. Representative overlaid
histogram shows binding of FAg to cells inhibited by unlabelled
FAg and absence of inhibition by chitinase treated FAg or sodium
Meta periodate treated deglycosylated FAg. C-In silico analysis
between chtx and TLR4. Three dimensional molecular docking
between chtx and extra cellular domain of mouse TLR4 was
performed using patch dock software demonstrating the interac-
tion of chtx to the internal pocket of extra cellular domain of
TLR4.
(TIF)
Figure S4 FAg or chtx induce expression of Ym-1 and
Arginase-1 in both in vitro and in vivo. BMDM of BALB/c
mice were treated with FAg or chtx for 48 hrs. and were analysed
for expression of Ym-1(A–D, isotype control, basal, FAg and chtx
respectively) and Arginase-1 (E–H isotype control, basal, FAg and
chtx respectively) by intracellular staining. Representative dot plots
show FAg or chtx induced expression of Ym-1 and Arginase-1 in
CD14+ve mouse macrophages. I,J: BALAB/c mice were injected
intraperitoneally with LPS (15 mg/Kg body weight) or chtx
(250 mg/animal) and after 90 mins peritoneal cells were harvested,
washed and stained for Ym-1 or Arginase-1 and analyzed for
expression in CD14+ve cells and is shown as histograms.
(TIF)
Figure S5 Monocytes of subjects with active filarial
infection are less responsive to LPS induced signaling.
(A,B,C) PBMCs of subjects with active filarial infection and
endemic controls were cultured in sterile Dulbecco’s modified
eagles medium containing 10% autologus plasma in humidified
atmospheric condition (5% CO2, 80% humidity). After 8–10 hrs
incubation at 370C non adherent cells were removed by washing
with sterile medium. The remaining adherent cells were stimulated
with different concentrations of LPS for 48 hrs. The culture
supernatants were analyzed for TNF-a (A), IL-1b (B) and and IL-6
(C). N=6 for CFA2ve and 5 for CFA+ve. * P,0.001, versus
CFA2ve cells (Student’s t-test).
(TIF)
Figure S6 Test of purity of adherent cells. Washed mouse
bone marrow cells in DMEM were seeded in 24 well plates at
0.5610
6 cells/well and incubated for 8–10 hrs at 37uC. Non
adherent cells were removed by washing with sterile DMEM and
the adherent cells were stained for CD14 (Figure S.6 B) along with
isotype controls (Figure S.6 A).
(TIF)
Table S1 Real time PCR was performed for the
following genes IL-1b, IL-6, TNF-a, IL-12 and iNOS and
GAPDH control using RNA purified from BMDM
stimulated with LPS or Chitohexaose. Details of primers
used for quantitative real time (QRT) PCR study are shown in
Table S1.
(DOC)
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